Skip to main content
PLOS One logoLink to PLOS One
. 2020 Nov 16;15(11):e0242213. doi: 10.1371/journal.pone.0242213

A profession in danger: Stakeholders’ perspectives on supporting the pharmacy profession in Lebanon

Mohamad Alameddine 1,2, Karen Bou-Karroum 1, Sara Kassas 1, Mohamad Ali Hijazi 3,*
Editor: Vijayaprakash Suppiah4
PMCID: PMC7668569  PMID: 33196652

Abstract

Background

Lebanon boosts one of the highest pharmacists to population ratios globally (20.3/10,000). Yet, workforce analysis elicited serious concerns with the distribution, practice environments and regulation of Lebanese pharmacists. Recent workforce data shows that the profession has been majorly destabilized with hundreds of pharmacists closing their pharmacies or losing their employment. Proper planning for the future of the pharmacy profession in Lebanon necessitates a deeper understanding of the current challenges and the necessary policy and practice recommendations. The aim of this study is to examine stakeholders’ perspectives on the current pharmacist workforce challenges and the necessary measures to support the profession.

Methods

The research team carried out a series of semi-structured interviews with twenty-one key stakeholders within the pharmacy profession in Lebanon. We categorized stakeholders according to their experience as policy makers, practitioners, academicians, and media experts. The interview guide included questions about workforce trends, labor market challenges and recommendations for improvement. Interviews were transcribed and analyzed thematically.

Results

Four major themes emerged from this study: the oversupply of pharmacists in Lebanon, the demand supply imbalance, poor regulation of the pharmacy practice, and the difficult practice environment. There was a consensus among interviewees that the oversupply of pharmacists is due to the poor workforce planning and weak regulatory framework, combined with the easy integration of foreign-trained pharmacists into the labor market. The lack of coordination between the educational and practice sectors is further widening the demand-supply gap. Interviewees further revealed that the regulatory policies on pharmacy practice were outdated and/or weakly enforced which increases the risk of unethical practices and erodes the image of pharmacists in the society. With respect to the practice environment, there is an ongoing struggle by Lebanese pharmacists to maintain profitability and exercise their full scope of practice.

Conclusion

The poor pharmacy workforce planning and regulation is significantly weakening the pharmacy profession in Lebanon. A concerted effort between the various stakeholders is necessary to enhance workforce planning, regulate supply, optimize the integration of pharmacists into work sectors of need, and improve the financial and professional wellbeing of pharmacists in Lebanon.

Introduction

In the last several decades, the pharmacy profession has shifted from a product-oriented profession to a patient-oriented one [1]. Nowadays, pharmacists are expected to function as caregivers, decision-makers, communicators, managers, life-long learners, teachers, leaders and researchers [2]. With the rapidly aging population and increased usage of medicines, the demand for medication experts has increased [3]. These changes contributed to the increased student enrollment and expansion of pharmacy schools [1]. Several countries including the United States and the United Kingdom, were concerned that this rapid expansion might have detrimental effects on the future workforce. Similar apprehensions have emerged in Lebanon (an Eastern Mediterranean country), which has seen an expanding market of pharmacy schools and an increasing number of pharmacy graduates [4].

Countries all over the world regularly assess the number of pharmacists needed in response to population density and market demands. Such assessments are necessary to avoid workforce imbalances (oversupply or undersupply). The oversupply of healthcare professionals is associated with the risk of unemployment and/or precarious work. Precarious work leads to dissatisfaction and consequently, to poor mental health and burnout [4]. In addition, the oversupply of pharmacists results in reduced salaries and increased workforce casualization as the demand decreases [5]. As such, many countries have implemented policy measures to limit the number of pharmacy students [1].

The pharmacy workforce local context

Lebanon is a small Eastern Mediterranean developing country with an estimated population of around five million citizens added to an estimated two million Syrian and Palestinian refugees [6]. According to the Order of Pharmacists of Lebanon (OPL), the Lebanese population is served by 8,800 pharmacists, registered with the OPL. Pharmacy students can graduate with a bachelor’s in pharmacy degree (5-year pharmacy program) or a PharmD. degree (6-year pharmacy program). There are five universities in Lebanon that have pharmacy programs, with a number of private universities seeking approval to open pharmacy schools from the Ministry of Education and Higher Education (MEHE). Lebanese pharmacy programs graduate 190–240 pharmacists per year [4]. Due to the absence of a national plan guiding the supply and utilization of pharmacists, there is no accurate database on the exact distribution of degrees awarded between the B.S. and the Pharm.D.

A recent examination of the pharmacist workforce trends and distribution in Lebanon revealed a significantly high pharmacist to population ratio of 20.3 pharmacists per 10,000 population. The study also indicated a high ratio of pharmacies to population, resulting in limited profitability and dissatisfaction among community pharmacists, coupled with negative influences on their professional status. Despite the oversupply of pharmacists, Lebanon has a modest number of hospital pharmacists. In fact, the hospital pharmacists’ role is limited to dispensing medicines, compounding, and cost management rather than practicing the clinical role they have been trained to serve [7]. Workforce analysis also reveals a low ratio of community pharmacists to pharmacies in Lebanon, which raises concerns over the workload, working hours, and the quality of services delivered [7].

Over the last few months, Lebanon’s worsening economic crisis combined with anti-government protests and the COVID-19 pandemic, have had dire consequences on the pharmacy profession. The OPL confirmed that the number of closed pharmacies exceeded 200, and about 1000 pharmacies are at risk of shutting down due to the reduction in prices of pharmaceutical products and the reduced purchasing capacity of citizens [8, 9]. Lebanon’s pharmaceutical importers are also struggling with the economic meltdown and currency depreciation and are voicing concern with an imminent shortage in the supply of essential drugs [10]. Under such circumstances, it comes as no surprise that the incidences of pharmacy theft have seen a remarkable upsurge adding to the woes of pharmacists in Lebanon [11].

Proper planning for the future of the pharmacy profession in Lebanon necessitates a deeper understanding of the current challenges and the necessary policy and practice recommendations to improve the workforce planning and working conditions. Recent studies have provided a better understanding of the numbers and distribution of pharmacists in Lebanon, yet a more comprehensive understanding of the specific workforce issues and their underlying causes is still lacking. The aim of this study is to examine pharmacy stakeholders’ perspectives on the current pharmacist workforce challenges and the necessary measures to support the profession.

Methods

Sampling and data collection

This research employed a qualitative design utilizing semi-structured key informant interviews. A number of key stakeholders were identified to help understand workforce trends, describe workforce challenges, and suggest corrective actions. Interviewees were invited to participate based on their knowledge of the field and engagement in the supply, regulation and/or organization of the profession. A review of public records was carried out to identify a number of key stakeholders in the public domain, those constituted the seed list and were interviewed first [12]. Snowball sampling was utilized during the interviews and the interviewees were asked to underscore the names of other experts whom they recommend the research team to interview [13]. The research team kept interviewing until there were no more experts to recommend and no new themes were emerging [14]. At the end of the study, twenty-one diverse stakeholders within the profession were invited to participate. The variability of interviewees across geographical locations (e.g. across the six Governorates of Lebanon) and institutions was ensured. They were categorized according to their work experience under policy-makers, practitioners, academicians, and media (Fig 1).

Fig 1. Categorization of interviewees.

Fig 1

The majority of the interviewees had experience in policy-making. They were divided into those who had experience in the Order of Pharmacists in Lebanon (OPL), Ministry of Public Health (MOPH), Parliamentary Health Committee, and Syndicate of Hospitals in Lebanon. All policy makers had extensive experience in the pharmacy labor market in Lebanon (owner of community pharmacies, work at or own a pharmaceutical company, working at pharmaceutical industries, etc.). Interviewed practitioners included two community pharmacists, three chief hospital pharmacists, and two owners of pharmaceutical industries. They were all registered pharmacists from various areas of the country. One of the community pharmacists was also a journalist and an advocate of human rights. The remaining interviewees were one health journalist and four academicians, including two key decision makers/Deans of Faculties of Pharmacy, and two Professors of Pharmacy at local universities.

The research team invited each of those interviewees via email. Upon the receipt of the consent to participate in the study, the interview was scheduled at a time and place of convenience to the interviewee. The research team shared a recently published workforce analysis with the interviewees before conducting the interviews to provide them with the latest evidence. By the end of the study, a total of 21 single face-to-face semi-structured interviews were conducted. All interviews were digitally recorded (with the interviewees consent) and lasted between 15 and 40 minutes. Interviews continued until the saturation point was reached no new information was identified [14].

The interview guide was developed based on existing literature and the objectives of the study. It included questions about the interviewees’ perspectives on workforce trends, labor market challenges and recommendations for improvement. Probing questions were asked to gain a better understanding of interviewees’ views and comments [15]. As such, interviewers asked clarifying questions such as “why do you think this is the case”, “what do you think is at the root cause of this problem?”. Below is a copy of the interview schedule used in this study:

  1. Please describe your experiences in the pharmacy sector in Lebanon?

  2. What is your opinion on the labor market of Lebanese pharmacists?
    • What needs to be improved?
    • Why do you think this is the case?
  3. What necessary measures need to be implemented to ensure future balance in the pharmacy labor market in Lebanon?
    • Why would these measures be important?
    • How could they be implemented?
  4. What are the requirements to upscale the role of pharmacist in Lebanon?
    • What are the impediments?
    • What needs to be done to overcome them?
    • Who are the responsible parties?
  5. How do you describe the practice environment of pharmacists in Lebanon?
    • Why do you think this is the case?
    • How do you think this could be improved?
  6. Are there any additional issues or improvements you wish to highlight?

  7. Who else should we speak with to help answer our questions?

Data analysis

The interviews conducted were fully transcribed. Transcribed interviews were comprehensively read to gain preliminary insight into the data. Transcripts were then imported to Dedoose, a qualitative analysis software [16]. All transcripts were read thoroughly by two members of the research team who met regularly to resolve disagreements in qualitative coding. Disagreements were discussed until consensus was reached. We used the grounded theory approach in our analysis, a process of coding that uses phrases and terms used by interviewees for developing codes [17]. Two members of the research team completed inductively, line-by-line coding for the transcripts without the use of a priori coding scheme. Codes were attached to excerpts, and an initial set of codes was developed from the recurring ideas and discussion points. Multiple rounds of co-coding were applied until consensus on codes definitions was reached. Duplicate codes were removed and overlapping codes were merged. Then, the identified set of codes was explored to form sub-themes from the conceptually related codes. Finally, sub-themes were grouped to form overarching themes. The themes were applied to each transcript, with amendments made if new codes emerged. The final list of themes and sub-themes was approved by all research team members [18].

Ethical considerations

This study was approved by the Institutional Review Board of both the American University of Beirut (Protocol number SBS-2019-0103) and Beirut Arab University (Protocol number 2019H-0060-P-R-0301). A written or oral informed consent was obtained from all interviewees. Confidentiality and anonymity of interviewees were guaranteed. Interviewees had the right to refrain from answering any questions and to end the interview at any time during the interview.

Results

The thematic analysis of interview data generated four major themes and eleven associated subthemes (Table 1).

Table 1. Overview of the main themes that emerged from the qualitative analysis.

Themes Sub-themes
1. Contributing factors to the oversupply of pharmacists in Lebanon.
  • Poor regulation of supply.

  • No barriers to the integration of foreign trained pharmacists to Lebanon.

  • Public perception of the pharmacy profession.

2. The demand-supply imbalance in the pharmacist workforce.
  • Need for additional investments in the pharmaceutical sector.

  • Need to utilize the full scope of pharmacy practice

3. Poor regulation of the pharmacy practice.
  • Outdated regulatory policies on pharmacy practice.

  • Insufficient monitoring of the practice of community pharmacists.

  • Ethical concerns and conflicts-of-interest.

4. Difficult practice environment
  • Decreased profitability of community pharmacists.

  • Undermining the role of pharmacy professional.

  • Work overload and long shifts in the pharmacy profession.

Contributing factors to the oversupply of pharmacists in Lebanon

Poor regulation of supply

Many interviewees acknowledged that the high number of pharmacy graduates was due to the lack of adequate assessment of the number of pharmacists needed relative to the total population number. They mentioned that the MOPH, OPL, and MEHE are responsible for conducting these assessments. Several interviewees referred to this restriction on the number of pharmacy graduates as “numerus clauses”, used by governments in several other countries:

“There is something called ‘numerus clauses’ that other countries apply. It specifies the number of pharmacists that the population needs…and accordingly there is an exam that places criteria on who is to be accepted into pharmacy.”

(Policy Maker 6)

No barriers to the integration of foreign trained pharmacists to Lebanon

Several interviewees agreed that the number of graduates inside the country and those coming from abroad were contributing to the increased number of pharmacists in Lebanon. They noted that pharmacists who studied abroad were encouraged to practice in Lebanon due to the ease of integration into the labor market. All that is required is just to pass a simple written and oral exam. Interviewees highlighted the importance of limiting the return of pharmacists from abroad rather than limiting the number of students admitted into pharmacy schools as the latter might negatively affect the financial status of universities and the quality of education.

“If you limit the number of graduates, will universities be able to continue paying for professors…I want to limit the numbers of pharmacists coming from abroad and maintain those in Lebanon.”

(Community practitioner 2)

Public perception of pharmacy profession

Interviewees mentioned a combination of factors that encouraged students to pursue pharmacy education, and leading to the oversupply of graduates. These factors include viewing pharmacy as a prestigious and profitable profession, with many benefits that could be earned from the OPL upon registration.

“A lot of people are studying pharmacy because they have a misconception that a pharmacy makes a lot of money”

(Policy maker 4)

The OPL has a very good retirement plan…and a good insurance…So it is attractive to working and retired pharmacists”

(Policy maker 9)

The demand-supply imbalance in the pharmacist workforce

Need for additional investments in the pharmaceutical sector

Interviewees noted that the inadequate investment in the various pharmaceutical sectors was widening the demand-supply gap. As such, they suggested creating more job opportunities in research, academia, and manufacturing.

“Create new job opportunities in research. In Lebanon Pharmacists mainly work as medical representatives, in regulation, community, hospital. Outside Lebanon they work in research, local manufacturing, academia”

(Policy maker 6)

Other interviewees elaborated that the development of the pharmacist educational programs was not matched with an advancement in pharmacy practice.

“The pharmacy education has greatly advanced whereas…the practice of pharmacists has not changed much.”

(Dean of pharmacy school 1)

Need to utilize the full scope of pharmacy practice

Several interviewees acknowledged that the root of the problem was not the high number of graduates, but the misallocation of pharmacists in their proper roles. Interviewees added that the mismatch between pharmacy education and the actual practice was a contributing factor for their inability to find jobs. For example, many interviewees thought that pharmacists were not exercising their full scope of practice and were rather overqualified for the type of services they were providing.

“There is lack of planning, lack of appreciation, limited professional development, all of this limits the pharmacists in their roles…Pharmacists have studied a lot but they are not permitted to implement what they have learned.”

(Dean of pharmacy school 2)

Poor regulation of the pharmacy practice

Outdated regulatory policies on pharmacy practice

According to interviewees, the poor regulation of the pharmacy profession in the country has led to several workforce challenges. The laws were either absent, or not being implemented, or needed updating. For example, according to law, opening a new pharmacy requires a 300 meters distance between the closest pharmacy, instead of the population number or the region needs, leading to numerous pharmacies opening in a certain area.

“Today we have to get out of the idea that pharmacies should be 300 meters apart, to the idea of the need of the population for pharmacies. And this should be studied at the Ministry of Health.”

(Community practitioner 2)

Most of the interviewees attributed the lack of hospital pharmacists in the country to the absence of a law that specifies the number of hospital pharmacists per bed.

If a law is not present to mandate the presence of a certain number of pharmacists per a specific number of beds, hospitals will be the ones taking this decision”

(Hospital pharmacist 3)

Insufficient monitoring of the practice of community pharmacists

Another challenge in the community pharmacy sector was the absence of close supervision on pharmacist’s practice and the implementation of laws by the relevant authorities. Interviewees articulated that some pharmacists were dispensing drugs without medical prescription or placing discounts on some of the products, thus, violating article 80 of the law on drug pricing.

“In community pharmacies there are lots of drugs that are sold without a prescription for the purpose of making profit…the MOPH should have a bigger regulatory role”

(Health journalist)

Ethical concerns and conflicts-of-interest

Corruption was noted by interviewees as an aspect of the governmental authorities that led to the poor regulation of the pharmacy profession. One interviewee identified that conflicts-of-interest between members of different governmental bodies hampered the formulation of health-related laws.

“Decisions are not based on evidence, but rather on financial considerations.”

(Policy Maker 8)

Multiple interviewees pointed out that in the absence of regulatory policies, the high number of pharmacies will lead to unethical practices or competition between community pharmacists.

“Competition between pharmacies and illegal practices arise when the number of pharmacies exceeds the needs of the population, which is the case in some areas in Lebanon.”

(Community practitioner 2)

Difficult practice environment

Decreased profit in the community pharmacy sector: Implications on practice

Most of the interviewees referred to the reduction in the price of drugs as the major contributing factor to the decreased profit in community pharmacies. The price of drugs was reduced, which significantly decreased the profit margin of community pharmacists and hindered their ability to employ additional pharmacists as required by the Lebanese law. Interviewees emphasized that the low pharmacists to pharmacy ratio was not due to the poor law implementation, but it was due to the lack of profit in the sector itself.

“The government lowered the prices without going back to the order of pharmacists…they should have increased the profit margin to compensate for the pharmacists’ losses.”

(Community practitioner 1)

Undermining the role of pharmacy professionals

Many interviewees elaborated that stakeholders in different sectors are playing a major role in underestimation of pharmacists and preventing them from widening their scope of practice to apply their professional skills as health care providers. Furthermore, the lack of collaboration between pharmacists and other healthcare professionals was raised by many interviewees as a reason behind undermining the profession.

“Pharmacists in general do not have the chance to practice their full scope due to the perception of a conflict with other health care providers, which should not be the case if collaboration exists among health care providers”

(Professor of pharmacy 2)

Interviewees discussed how the roles of community pharmacists were limited to the dispensing and selling of medications. They added that the pharmacists’ scope of practice should be inclusive of other roles such as medical counselors, educators, and advocates.

“A pharmacist’s role is not in dispensing medications, it should include exchanging a medication with a cost-effective alternative- the generic to replace the brand.”

(Policy maker 1)

Work overload and long shifts in the pharmacy profession

Interviewees raised the issue of long working hours and work overload in community pharmacies since usually only one pharmacist has to deal with multiple tasks. Consequently, some pharmacists reported feeling fatigued after working for long hours.

“A pharmacist doing all the pharmacy work all through the day with no specific shift, will feel physically and psychologically fatigued”

(Policy maker 5)

Hospital pharmacists were also affected by the heavy workload in the hospitals. As noted by the interviewees, this was mainly due to the limited number of hospital pharmacists who are not able to properly carry out the required tasks.

“One pharmacist alone cannot be responsible for stock management, dispensation, and managing the pharmacy operations plus having a clinical role.”

(Hospital pharmacist 3)

Discussion

In this study, stakeholders asserted that the pharmacy profession in Lebanon requires a concerted effort by concerned stakeholders to ensure workforce optimization and improve working conditions. The supply of pharmacists is poorly planned and regulated leading to a situation of oversupply. The demand for pharmacists, on the other hand, is focused on the community pharmacy sector at the expense of other sectors that contribute to the health and wellbeing of the population (e.g. clinical pharmacists, manufacturing, etc.). These factors, added to insufficient investment in the pharmaceutical sector, is widening the demand-supply gap in the pharmacy labor market in the country. Most interviewees expressed concern that the situation of the pharmacy profession calls for immediate interventions to protect it from further deterioration and to enable pharmacists to exercise their full scope of practice in serving the population.

Interviewees described an obvious oversupply of pharmacists, which is expected to exacerbate, as the number of new pharmacy graduates continues to surpass the number of available jobs. This is related to both internal and external factors. On one hand, the number of pharmacy schools and graduates in Lebanon is not optimized to the national needs. On the other hand, foreign trained pharmacists could get easily licensed to practice after passing oral and written examinations [4]. According to OPL, the majority of foreign trained pharmacists originated from neighboring Arab countries, Eastern European countries and Russia. Although the number of those pharmacists have decreased over the years, they still represent about 30% of active pharmacists. The easy integration of foreign trained pharmacists into the Lebanese health system was indeed a contributing factor in creating a surplus [7]. In contrast, most countries (including the neighboring ones in the Middle East Region) have strong regulatory requirements that highly restrict (or ban) the integration of foreign trained pharmacists into their labor markets. In addition, there is no agreement between Lebanon and other countries that enables pharmacists trained in Lebanon to practice outside. This can explain why only 8% of pharmacists trained in Lebanon are reporting practicing outside the country [7], despite the highly qualified and internationally accredited pharmacy programs in Lebanon. Over the years, the supply of pharmacists has exceeded the demand and regulatory requirements did not support the integration of the surplus into the system of other countries.

Perhaps more disconcerting, is the absence of a national health human resources forecasting model to advise on the current and future needs for pharmacists in Lebanon [4, 7]. This has contributed to the lack of coordination between the educational and practice sectors. Hence, a forecasting model is urgently needed to advise on the current and future needs of pharmacists in the various sectors of employment. Forecasting and analyzing future workforce trends require a comprehensive assessment, with consideration to the demographic characteristics of the workforce, training and education schemes, changes in pharmacist roles, and technological advancements in the profession [1]. The planning and forecasting exercise will not be an easy task in Lebanon as it requires the consolidation of data from various stakeholders and a partnership with academic institutions and development partners to ensure the validity of the generated models. An additional challenge lies in the lack of accurate population statistics and the continuous movement of refugees to and from the country. Having said that, the forecasting models, even if they were less accurate, would be instrumental to guide the pharmacy workforce development in the future. This forecasting process should include representatives from the MOPH, OPL, academic and research institutions, regional and international agencies and various pharmacy practice sectors. The forecasting model has to be coupled with a regulatory framework to right-size the supply of pharmacists and set a strategic health human resources plan focused on the pharmacy profession.

One of the proposed solutions is to remedy workforce oversupply is to implement “numerus clausus”, which designates the number of students admitted each year. This has been applied in several developed countries and proved to be effective in regulating workforce trends without negatively affecting patients or the profession [1]. Within the Lebanese context, capping admissions to pharmacy schools will be difficult to implement and would violate the very nature of the Lebanese free market educational sector. Furthermore, even if “numerus clausus” is successfully implemented, it would not be enough to rectify the imbalances in the market unless coupled with other policy options.

The experiences of other countries will be helpful on that front including: expanding the scope of practice of pharmacists [19], diversifying their specializations as per the needs of the market [4], facilitating the integration of the surplus of pharmacists into regional and international labor markets experiencing a shortage [20], and restricting the integration of foreign trained pharmacists in to the labor market. Again, bringing balance to the labor market would require a concerted effort of the various pharmacy sector stakeholders and the building of a consensus on a strategic direction and regulatory options.

However, capped university admissions and restricting the integration of foreign-trained pharmacists would not bring a quick respite to the practicing pharmacists in Lebanon. In fact, effective utilization of the current pharmacists’ workforce represents a prompt solution for the country with long-term benefits [21]. Certainly, more efforts should be directed towards investing in various pharmaceutical sectors including research, academia, manufacturing, and clinical practices. For example, there is evidence that pharmacists in Lebanon were underutilized in the hospital sector. The ratio of hospital pharmacists to hospitals was 1.9 pharmacists, with pharmacists mainly practicing their dispensary role rather than the much needed clinical responsibilities [7]. Lebanon could follow the example of other countries in the region by mandating a minimum ration of clinical pharmacist to patients in Lebanese hospitals [22, 23].

As a matter of fact, regulating pharmacists supply and creating cross-sector ob opportunities require prompt governmental regulations [24]. Other countries have enabled pharmacists to exercise their full scope of practice, for example, community pharmacists in the UK have been involved in research [25, 26], health coaching [27], as well as patient assessments and population-based programs [28]. If this can be achieved successfully in Lebanon, the profession could be up-scaled with pharmacists practicing as patient educators and population health agents. With the fast-changing environment that is witnessed globally, it is imperative to ensure a nimble, dynamic and evidence based regulatory process. Therefore, any intervention should be coupled with ongoing monitoring and periodic review of supply and demand in order to capture unintended consequences and address them in a timely manner.

Additionally, interviewees reported that the weak monitoring and evaluation of the implementation of existing laws and guidelines is hindering the development of the workforce. For instance, the regulatory policies that mandate the presence of pharmacists in their pharmacies throughout the operating hours is poorly enforced. This is undermining the role of pharmacists as medicine and drug experts. Interviewees further report unethical or illegal practices, including: switching prescribed drugs (without the consent of the prescriber), offering discounts to lure customers, promoting drugs and products based on incentives offered by companies and distributors, and dispensing drugs without a prescription. As such, adequate monitoring of pharmacy practice is essential to ensure the safety and quality of the delivered services [29]. Moreover, interviewees raised concern with the lack of joint governance which leads to negative spillover effects on the profession of some of the governmental policies (e.g. reduction on drug prices without revising the business model of pharmacists).

Literature emphasize that good governance is key for achieving good pharmacy practice [29, 30]. Many interviewees described a general lack of trust in the role of the governing bodies due to corruption, incompetence and conflicts-of-interest. This constitutes a major barrier towards enforcing regulatory policies. Reinforcing trust is a prerequisite to successful and sustainable policy implementation that can improve pharmacy practice [30]. Joint governance is essential for maintaining high standards of care and improving quality of services [31]. The OPL efforts to rectify the labor market anomalies have not been successful with the government. For example, although the health committee of the Lebanese parliament has accepted the suggestions from OPL regarding implementation of clinical pharmacists in hospitals (accepted in September 2018) and the limitation on the number of pharmacy graduates (accepted in March 2019), the two laws have yet to be implemented [32].

This study identified other challenges for pharmacy practice in Lebanon, including lack of appreciation of pharmacists’ role, poor interprofessional collaboration, and poor working conditions. Despite the significant changes that the pharmacy profession has witnessed worldwide, the poor recognition of pharmacists is still common in developing countries. Furthermore, the lack of collaboration between pharmacists and other healthcare professionals, especially physicians, was raised by many interviewees as a reason behind undermining the profession [33, 34]. Literature emphasize the importance of having open communication between healthcare professionals and respect for each other’s roles [35]. Inter-professional collaboration has been reported in several studies as a driver for advanced pharmacy practice. It is a recognized benefit for pharmacists and a desirable component of patient-centered care, leading to better patient outcomes [36]. Hence, it is essential to articulate the importance of pharmacists as the medicinal and drug experts. This could be achieved through integrating pharmacists in outreach programs and national campaigns promoted by OPL and the MOPH.

Furthermore, study findings identified poor working conditions, such as long working hours and work overload. Given the increased competition between community pharmacies and the inability of pharmacy owners to hire pharmacy assistants, community pharmacists have to work for long hours [31]. Similar workplaces stressors have been reported in several countries such as the United Kingdom, Canada, and the United States [37]. These issues raise several concerns regarding pharmacists’ well-being and patient safety. Thus, working conditions must be monitored and improved by relevant authorities. Stakeholders must ensure that the workforce is adequately staffed, qualified, and utilized to complete the required tasks. They must prioritize pharmacists’ physical, mental, and psychological well-being. Additionally, employers and schools of pharmacy should establish support programs with various resources and strategies that can improve the well-being and resilience of pharmacists [38].

Limitations

A number of shortcomings in this study warrant mentioning. First, the interviewed stakeholders may not represent the views of all experts involved in the pharmacy practice. Yet, the views expressed by interviewees suggest a shared understanding among all stakeholders. Second, the authors cannot rule out stakeholders’ own impressions and biases. However, the research team minimized the biases through identifying recurrent themes and by asking interviewees to provide further elaboration/evidence for unsubstantiated comments. In addition, the authors ensured that the questions in the interview guide are simple, non-leading, with minimal wording bias to avoid influencing the responses of the interviewees. Finally, the study could benefit from a stronger voice for the civil society. Regretfully, the country does not have civil society organizations/NGOs with the required level of knowledge in the field. The experienced opinion of impartial academicians and the media was utilized as a proxy to the voice of the civil society.

Conclusion

The current situation in the pharmacy labor market in Lebanon is detrimental to the financial and professional wellbeing of Lebanese pharmacists and may jeopardize the quality and safety of service extended to the population. A concerted effort, led by the MOPH and OPL, and involving the stakeholders, is necessary to enhance workforce planning, regulate supply, optimize the integration of pharmacists into work sectors of need and to enhance the financial and professional wellbeing of pharmacists in Lebanon. Such efforts, if successful, could transform a profession in danger into a major contributor to the health and wellbeing of individuals and communities.

Acknowledgments

The authors wish to extend deep gratitude to all the interviewees who took time off their busy schedule to contribute to this study. The authors are also indebted to the Order of Pharmacists in Lebanon for supporting this study.

Data Availability

Data cannot be shared publicly because it contains potentially identifying information of human subjects. Data are available from the American University of Beirut Institutional Data Access/Ethics Committee (contact via email: irb@aub.edu.lb) for researchers who meet the criteria for access to confidential data.

Funding Statement

This study was funded by the University Research Board of the American University of Beirut, received by MA. Award number 103785- Project number 25278.

References

  • 1.Covvey JR, Cohron PP, Mullen AB. Examining pharmacy workforce issues in the United States and the United Kingdom. American journal of pharmaceutical education. 2015;79(2). 10.5688/ajpe79217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.WHO. The Role of The pharmacist in Self Care and Self Medication. Geneva. 1994.
  • 3.Watanabe JH. Examining the Pharmacist Labor Supply in the United States: Increasing Medication Use, Aging Society, and Evolution of Pharmacy Practice. Pharmacy. 2019;7(3):137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hallit S, Sacre H, Hajj A, Sili G, Zeenny RM, Salameh P. Projecting the future size of the Lebanese pharmacy workforce: forecasts until the year 2050. International Journal of Pharmacy Practice. 2019;27(6):582–8. 10.1111/ijpp.12564 [DOI] [PubMed] [Google Scholar]
  • 5.Lebovitz L, Eddington ND. Trends in the pharmacist workforce and pharmacy education. American Journal of Pharmaceutical Education. 2019;83(1). 10.5688/ajpe7051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Statistics CAo. Labour Force and Household Living Conditions Survey 2018–2019 Lebanon. 2019.
  • 7.Alameddine M, Karroum KB, Hijazi MA. Upscaling the pharmacy profession in Lebanon: workforce distribution and key improvement opportunities. Human resources for health. 2019;17(1):47 10.1186/s12960-019-0386-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Xinhua. Pharmacies in Lebanon faces shutdown as medicine prices continue to fall. 2020. http://www.xinhuanet.com/english/2020-01/21/c_138724338.htm
  • 9.Anbaa. قطاع جديد يعاني…نقيب الصيادلة لـ"الأنباء": نتوقّع إقفال 1000 صيدلية. 2020. https://anbaaonline.com/news/69618
  • 10.Kantarjian P. Will dollar scarcity lead to medicinal shortages? 2020. https://en.annahar.com/article/1189991-will-the-dollar-shortage-lead-to-medicinal-shortage
  • 11.Elnashraسوق سوداء سبب عمليات سرقة الصيدليات في لبنان؟. 2020. https://www.elnashra.com/news/show/803250/سوق-سوداء-سبب-عمليات-سرقة-الصيدليات-لبنان؟
  • 12.Robinson OC. Sampling in interview-based qualitative research: A theoretical and practical guide. Qualitative research in psychology. 2014;11(1):25–41. [Google Scholar]
  • 13.Goodman LA. Snowball sampling. The annals of mathematical statistics. 1961:148–70. [Google Scholar]
  • 14.Strauss A, Corbin J.(1998). Basics of qualitative research: Techniques and procedures for developing grounded theory. Thousand Oaks, CA: Sage. 1998. [Google Scholar]
  • 15.Turner DW III. Qualitative interview design: A practical guide for novice investigators. The qualitative report. 2010;15(3):754. [Google Scholar]
  • 16.Lieber E. Dedoose (Beginner Workshop)—Getting Started with Your Qualitative and Mixed Methods Data Management, Analysis, and Presentation. 2014.
  • 17.Khan SN. Qualitative research method: Grounded theory. International Journal of Business and Management. 2014;9(11):224–33. [Google Scholar]
  • 18.Maxwell JA. Designing a qualitative study. The SAGE handbook of applied social research methods. 2008;2:214–53. [Google Scholar]
  • 19.Brown DL. A looming joblessness crisis for new pharmacy graduates and the implications it holds for the academy. American journal of pharmaceutical education. 2013;77(5). 10.5688/ajpe77590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.OECD. Migration for Employment: Bilateral Agreements at a crossroads: OECD Publishing; 2004. [Google Scholar]
  • 21.Auta A, Strickland-Hodge B, Maz J. Challenges to clinical pharmacy practice in Nigerian hospitals: a qualitative exploration of stakeholders’ views. Journal of evaluation in clinical practice. 2016;22(5):699–706. 10.1111/jep.12520 [DOI] [PubMed] [Google Scholar]
  • 22.Kheir N, Fahey M. Pharmacy practice in Qatar: challenges and opportunities. Southern med review. 2011;4(2):92 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Alomi YA. A new guidelines on hospital pharmacy manpower in Saudi Arabia. Journal of Pharmacy Practice and Community Medicine. 2016;2(2). [Google Scholar]
  • 24.Bader LR, McGrath S, Rouse MJ, Anderson C. A conceptual framework toward identifying and analyzing challenges to the advancement of pharmacy. Research in Social and Administrative Pharmacy. 2017;13(2):321–31. 10.1016/j.sapharm.2016.03.001 [DOI] [PubMed] [Google Scholar]
  • 25.Crilly P, Patel N, Ogunrinde A, Berko D, Kayyali R. Community pharmacists’ involvement in research in the United Kingdom. Pharmacy. 2017;5(3):48 10.3390/pharmacy5030048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sarwar MR, Saqib A, Riaz T, Aziz H, Arafat M, Nouman H. Attitude, perception, willingness, motivation and barriers to practice-based research: A cross-sectional survey of hospital pharmacists in Lahore, Punjab, Pakistan. PloS one. 2018;13(9):e0203568 10.1371/journal.pone.0203568 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Lonie JM, Austin Z, Nguyen R, Gill I, Tsingos-Lucas C. Pharmacist-based health coaching: A new model of pharmacist-patient care. Research in Social and Administrative Pharmacy. 2017;13(3):644–52. 10.1016/j.sapharm.2016.06.015 [DOI] [PubMed] [Google Scholar]
  • 28.Jorgenson D, Dalton D, Farrell B, Tsuyuki RT, Dolovich L. Guidelines for pharmacists integrating into primary care teams. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada. 2013;146(6):342–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hermansyah A, Pitaloka D, Sainsbury E, Krass I. Prioritising recommendations to advance community pharmacy practice. Research in Social and Administrative Pharmacy. 2018;14(12):1147–56. 10.1016/j.sapharm.2018.02.003 [DOI] [PubMed] [Google Scholar]
  • 30.Hermansyah A, Sainsbury E, Krass I. Multiple policy approaches in improving community pharmacy practice: the case in Indonesia. BMC health services research. 2018;18(1):449 10.1186/s12913-018-3258-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sacre H, Hallit S, Hajj A, Zeenny RM, Sili G, Salameh P. The pharmacy profession in a developing country: Challenges and suggested governance solutions in Lebanon. Journal of Research in Pharmacy Practice. 2019;8(2):39 10.4103/jrpp.JRPP_19_5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Parliament L. لجنة الصحة العامة والعمل والشؤون الإجتماعية درست اقتراح تعديل المادة 3 من قانون مزاولة مهنة الصيدلة واقتراح القانون الرامي إلى تثبيت مستخدمين في المؤسسة العامة للإسكان. 2019. https://www.lp.gov.lb/ContentRecordDetails.aspx?id=29221&title=لجنة-الصحة-العامة-والعمل-والشؤون-الإجتماعية-درست-اقتراح-تعديل-المادة-3-من-قانون-مزاولة-مهنة-الصيدلة-واقتراح-القانون-الرامي-إلى-تثبيت-مستخدمين-في-المؤسسة-العامة-للإسكان.
  • 33.Altman IL, Mandy PJ, Gard PR. Changing status in health care: community and hospital pharmacists’ perceptions of pharmacy practice. International Journal of Pharmacy Practice. 2019;27(3):249–55. 10.1111/ijpp.12505 [DOI] [PubMed] [Google Scholar]
  • 34.Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integrated pharmacy research & practice. 2017;6:37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.O’Reilly P, Lee SH, O’Sullivan M, Cullen W, Kennedy C, MacFarlane A. Assessing the facilitators and barriers of interdisciplinary team working in primary care using normalisation process theory: an integrative review. PloS one. 2017;12(5):e0177026 10.1371/journal.pone.0177026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Deeks LS, Kosari S, Naunton M, Cooper G, Porritt J, Davey R, et al. Stakeholder perspectives about general practice pharmacists in the Australian Capital Territory: a qualitative pilot study. Australian journal of primary health. 2018;24(3):263–72. 10.1071/PY17086 [DOI] [PubMed] [Google Scholar]
  • 37.Tsao NW, Lynd LD, Gastonguay L, Li K, Nakagawa B, Marra CA. Factors associated with pharmacists’ perceptions of their working conditions and safety and effectiveness of patient care. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada. 2016;149(1):18–27. 10.1177/1715163515617777 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.APHA. Enhancing Well-Being and Resilience Among the Pharmacist Workforce: A National Consensus Conference. 2019.

Decision Letter 0

Vijayaprakash Suppiah

1 Oct 2020

PONE-D-20-28091

A profession in danger: Stakeholders’ perspectives on supporting the pharmacy profession in Lebanon

PLOS ONE

Dear Dr. Hijazi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 15 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Vijayaprakash Suppiah, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the qualitative interview guide used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed an interview guide as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

3. In the Methods, please discuss whether and how the questionnaire was validated and/or pre-tested. If this did not occur, please provide the rationale for not doing so.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I think this is an interesting paper. The surplus of pharmacists is a troubling issue in many countries, including but not limited to Lebanon. This issue - especially the details of the mechanism by which market and policy forces may alleviate this surplus - have not been fully explored in the literature.

Being a purely qualitative study, the transparency of the study's details are especially crucial in determining whether the study is of sufficient technical and rigorous merit to warrant publication. Many of these details are missing. I will note a few major issues below, noting that the list is not exhaustive.

1. What is the distribution of degrees awarded between the B.S. and the Pharm.D. degree each year? Are these scope of practice differences? Is the PharmD exclusively intended to work in institutional or other advanced practice settings? We need to know whether the surplus of pharmacists is a function of structural academic characteristics before it is possible to interpret the results of your analysis.We also need to know more about the specific clinical roles of a pharmacist - what is in place currently versus the aspirations of the profession as a whole.

2. The study also consistently posits a clausus as a means to address the surplus. Would such a clausus violate antitrust or anti-collusion laws in Lebanon? Are there alternative policy or market responses that could be considered as viable responses? By including this discussion in the introduction (in the manner in which it is introduced) it potentially biases the reader towards only one of many responses.

3. On page 6, why would robberies contribute to the over-supply of pharmacists? Would it not lead to the opposite effect? Also, the authors note that pharmacists trained outside of Lebanon contribute to the surplus of pharmacists. From where do the primarily originate? Do Lebanese trained pharmacists have the ability to practice internationally? If so, where can they practice? One cannot discuss one side of the labor market without addressing the other.

4. More details are necessary to justify the research design. How did you arrive at a number of 21 stakeholders? There are many details and considerations beyond simply describing "purposive sampling" that must be described to ensure the study's accuracy and transparency. Why not 30? Why not 12? Holding constant the number of stakeholders, please explain why the distribution of the expertise and practice settings of the 21 stakeholders is sufficient to justify accurate, reliable and precise themes? Are they set proportionally to the distribution of practicing pharmacists? Or is there some other rationale to deviate from this proportionality? It seems the respondents are ore heavily weighted towards policy than towards other areas, most notably community practice (where most of the surplus is occurring). For your policy maker stakeholders, what is the scope of their work related to policy making? What do they do?

5. Did anyone decline to participate as a stakeholder? Were there people excluded from participating, and on what grounds?

6. The most glaring limitation of the study is that this reviewer was not able to view the actual interview questions and structure of the interview (preface, conclusion, etc.). The details of the wording of the interview questions (including their scope of coverage, but also the neutrality or slanting of the wording of the questions) is crucial in generating information and ultimately the creation of themes. The second paragraph on page 7 should therefore be expanded substantially to include these details.

7. What was the process (which should have been identified a priori to the study's implementation) by which possible disagreements in the creation of the themes were resolved?

8. Please better and more precisely explain what you mean by "A preliminary data analysis was performed in order to identify issues that need further investigation." This is highly ambiguous and be interpreted in many ways, some of which may undercut the legitimacy of the research. I am not saying this did happen, but it should be clarified to covey to a reader that it did not happen.

9. Please explain in more detail your coding process, what words and expressions were used to identify the key concepts. Again, this is the "art" of qualitative research, and it should be described in more detail so the readers know exactly what you are trying to accomplish.

10. The second "Contributing Factors to the Oversupply" of Pharmacists in Lebanon" is superficial and needs much greater development (greater depth of analysis), as well as tied to the literature. I think what is contained in this section is fine as a starting point. But there is really no information in each subsection that would not be intuitively obvious to an individual with (even rudimentary) knowledge of the industry. It is important to not only summarize the responses, but to use them to identify novel research questions or to identify previously undiscussed policy issues. For example, the first idea and subsection discusses the clauses concept identified in the introduction. OK; certain countries use clauses to restrict supply. Is the Lebanese educational system designed to enforce clauses? What would it take to enact a clausus in terms of reform to the pharmacy educational system? Was any stakeholder able to identify what the correct number of students admitted to pharmacy school is or approximately should be?

What is reported is too superficial to be of use to identifying research questions or specific directions for future policy research, which is the goal of any qualitative study.

Similar types of issues pervade the remainder of this section. Since this section touches on many major themes, it is infeasible to address points of detail for each of these sections, except to note that each point, while entirely valid in premise, should be expanded with depth of analysis to ensure that the manuscript appropriately and consistently accomplishes its objectives.

11. In the Conclusions section you mention the creation of a forecasting model. I think this is a good idea. However, there are two issues that should be addressed here. First, a model should forecast with a purpose, and include forecasts that anticipate or predict the effects of specific policy responses. Other than simply forecasting graduates and current openings, what should the model specifically address as the most pressing issue? Is it the clauses, expanded scope of practice, etc.? Second, forecasting itself is not a political process. The model is built to forecast phenomena based on the needs of policy holders. The results are used to inform policy actions. But the model itself should be designed and implemented based on rigorous scientific standards, not on the consensus of politicians or stakeholders.

Reviewer #2: The article is well written and establishes data to support its main points. The lack of a validated interview tool may be an important weakness to point out. The summary and analysis of the data in the results and discussion sections are clear and well explained.

It is challenging to remove writer, interviewer and interviewee bias from a manuscript like this. The authors attempt to reduce this and provide information in the limitation section. Perhaps even more emphasis of this point should be attempted in the limitation section.

More support could have been provided to the information about limitation of pharmacists from foreign graduates getting licensed could have been offered. Additionally, consideration of the impact/problems/issues that may result from overall more regulation should have been discussed further.

Thanks for this contribution to the literature and effort to undertake such an extensive interview process with stakeholders.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Nov 16;15(11):e0242213. doi: 10.1371/journal.pone.0242213.r002

Author response to Decision Letter 0


22 Oct 2020

Comments from Reviewer #1

The authors would like to extend their deep gratitude to the reviewer for the helpful feedback. We are delighted you found this article interesting and concur with you that the topic addressed by this manuscript requires further attention in literature. We found great value in your suggested edits and will use them as a guide to improve the writeup, comprehensiveness and clarity of this manuscript.

Please see below a point-by-point response to your comments and suggestions.

Comment 1.1: What is the distribution of degrees awarded between the B.S. and the Pharm.D. degree each year? Are these scope of practice differences? Is the PharmD exclusively intended to work in institutional or other advanced practice settings? We need to know whether the surplus of pharmacists is a function of structural academic characteristics before it is possible to interpret the results of your analysis. We also need to know more about the specific clinical roles of a pharmacist – what is in place currently versus the aspirations of the profession as a whole.

Response: We are happy to provide additional clarification on the distribution and professional scope of pharmacists in Lebanon. The country currently has five active universities offering pharmacy programs (4 private, 1 public). Pharmacy students can graduate with a bachelor’s in pharmacy degree (5-year pharmacy program) or a PharmD degree (6-year pharmacy program including clinical rotations). Due to the absence of a national plan guiding the supply and utilization of pharmacists, there is no accurate database on the exact distribution of degrees awarded between the B.S. and the Pharm.D.. Moreover, the number of Pharm.D. graduates fluctuates annually and depend on students' desire to pursue the program and on a university's capacity to offer the degree. Pharmacists with Pharm.D. degrees should in principle have an advantage over B.S. holders with respect to clinical practice. They are trained to work at hospitals as clinical pharmacists, on the floor, as consultants or in managed care. The clinical pharmacist’s role is to make sure patients understand and adhere to their medication regimen with respect to timing, dosage, and frequency during the prescribed length of time. In addition, the clinical pharmacist is trained to prevent potential adverse drug events by providing drug information in plain language to the patient at key transition times, such as hospital admission and discharge, as well as during the patient’s entire stay (Ghaibi et al., 2015). However, the practice of clinical pharmacists in Lebanon tells a different story, with a recent study revealing that they are primarily practicing their drug dispensing role rather than their clinical role (Alameddine et al., 2019). The average ratio of hospital pharmacists to hospitals was 1.9 in Lebanon, with an unfortunate absence of pharmacists from clinical floors or divisions. The hospital pharmacist’s role in Lebanon focuses on the distribution of medications, compounding, formulary review, and cost management. The aspirations for pharmacy stakeholders is for clinical/hospital pharmacists to exercise their full scope of practice, including: ensuring safe, appropriate, efficacious, judicious, and cost-effective use of medications while decreasing improper medication usage and enhancing the satisfaction of patients (Dalton & Byrne, 2017; Vaillancourt, 2011).

Comment 1.2: The study also consistently posits a clausus as a means to address the surplus. Would such a clausus violate antitrust or anti-collusion laws in Lebanon? Are there alternative policy or market responses that could be considered as viable responses? By including this discussion in the introduction (in the manner in which it is introduced) it potentially biases the reader towards only one of many responses.

Response: The reviewer makes a good point here. There are no antitrust or anti-collusion laws in Lebanon. Therefore, limiting the number of students does not violate antitrust laws. On the contrary, according to the Order of Pharmacists (OPL) and other experts in the field, limiting the number of graduates could potentially enhance the quality of pharmacy education. The clauses would be aligned with community needs and would not affect the competition between academic institutions.

Having said that, we concur with the reviewer that the suggested “clauses” is not the only policy option and it would not be enough if implemented on its own. Health authorities, education authorities and the OPL should work cooperatively to make the best use of pharmacy graduates and limit their surplus. Several suggestions were raised including the integration of more specialization in pharmacy education such as: pharmaceutical industries, research on drug discovery, consultant, care management, etc (Hallit et al., 2019). In addition, there is a necessity to expand the scope of practice and issue the law of clinical pharmacists (accepted by Parliamentary Health Committee on September 2018) that will utilize hundreds of qualified pharmacists that are Pharm.D holders or clinically certified (Brown, 2013). Another suggestion for policy makers is to create bilateral/multilateral agreements to facilitate the employment of the surplus of Lebanese pharmacists in countries that suffer from a shortage of pharmacists (OECD, 2004). FIP reported that pharmacists, in particular, are lacking in the workforce in many countries like those in Africa, South East Asian, and the Middle East (Bates et al., 2018). These options are mentioned in the manuscript on page 19-20.

Comment 1.3: On page 6, why would robberies contribute to the over-supply of pharmacists? Would it not lead to the opposite effect? Also, the authors note that pharmacists trained outside of Lebanon contribute to the surplus of pharmacists. From where do they primarily originate? Do Lebanese trained pharmacists have the ability to practice internationally? If so, where can they practice? One cannot discuss one side of the labor market without addressing the other.

Response: Robberies were listed under the challenges facing community pharmacists and thus it does not contribute to the oversupply of pharmacists. In fact, the increasing frequency of robberies is contributing to the burnout of pharmacists and is creating a risky work environment. We have clarified the point in the manuscript.

According to OPL, the majority of foreign trained pharmacists originated from neighboring Arab countries, Eastern European countries and Russia. Although the number of those pharmacists have decreased over the years, they still represent about 30% of active pharmacists. The easy integration of foreign trained pharmacists into Lebanese health system was indeed a contributing factor in creating a surplus (Alameddine et al., 2019). In contrast, most countries (including the neighboring ones in the Middle East Region) have strong regulatory requirements that highly restrict (or ban) the integration of foreign trained pharmacists into their labor markets. In addition, there is no agreement between Lebanon and other countries that enables pharmacists trained in Lebanon to practice outside. This could explain why only 8% of pharmacists trained in Lebanon are reporting practicing outside the country (Alameddine et al., 2019), despite the highly qualified and internationally accredited pharmacy programs in Lebanon. Over the years, the supply of pharmacists has exceeded the demand and regulatory requirements did not support the integration of the surplus into the system of other countries. This has been elaborated in the discussion in the manuscript (page 18).

Comment 1.4: More details are necessary to justify the research design. How did you arrive at a number of 21 stakeholders? There are many details and considerations beyond simply describing "purposive sampling" that must be described to ensure the study's accuracy and transparency. Why not 30? Why not 12? Holding constant the number of stakeholders, please explain why the distribution of the expertise and practice settings of the 21 stakeholders is sufficient to justify accurate, reliable and precise themes? Are they set proportionally to the distribution of practicing pharmacists? Or is there some other rationale to deviate from this proportionality? It seems the respondents are heavily weighted towards policy than towards other areas, most notably community practice (where most of the surplus is occurring). For your policy maker stakeholders, what is the scope of their work related to policy making? What do they do?

Response: We thank the reviewer for the valuable comment and appreciate the opportunity to further elaborate on our study design and methods. The number of interviews carried out in this study was not predetermined prior to the start of the study (our apologies if we were not clear on this point in the initial submission), but rather emerged as the authors reached the saturation point and the themes and subthemes became redundant (Strauss, 1998). We have explained our sampling process in more detail in the manuscript on page 6-7.

The Lebanese market is relatively small and stakeholders who can contribute to the profession are well-known and were all included in our sampling frame. As for academicians and practicing pharmacists, we had to sample those who are opinion leaders with lots of experience. The 21 stakeholders we ended up interviewing were from different regions and institutions in the country.

The Lebanese regulation allows policy makers at different levels (OPL, parliament, Ministry of health) to continue their community services at their own pharmacies or other institutions. Although most interviewed pharmacists were policy makers, most of them have many years of experience as community pharmacists. The participant list was chosen to represent all the Governorate of Lebanon. The experience of interviewed policy makers in the pharmacy labor market is represented below. Similarly, all other stakeholders have experience in the pharmacy labor market. The authors are ready to share the experience of all interviewees upon the reviewer’s request.

Interviewee Practice experience Policy experience Region

P1 Owner of Pharmaceutical company for more than 30 years

Owner of pharma drugstore for more than 20 years Current President of OPL

Former president of OPL (2003-2006; 1993-1996)

Member of OPL board for several years South Lebanon

P2, P3, P5 Owner of a community pharmacies for more than 20 years Former Presidents of OPL Beirut Governorate

Mount Lebanon Governorate

P5 Owner of community pharmacy for more than 25 years Active trustee of OPL North Lebanon

P6 More than 10 years experience in pharma companies Head of Pharmacy department at Ministry of Public Health Beirut Governorate

P7 Owner of Pharmacy for more than 15 years

10 years experience in pharmaceutical industry Health minister consultant for pharmaceutical issues South Lebanon

As is evident in the above Table, the various Governorates of Lebanon were represented. Having said that, and due to the small size of the country and the centralization of regulatory framework and policy making, the themes emerging from various stakeholders converged. In this study, the authors were more concerned with ensuring the thorough expertise of interviewees more than their regional representation.

Comment 1.5: Did anyone decline to participate as a stakeholder? Were there people excluded from participating, and on what grounds?

Response: Thanks for the opportunity to clarify this point. The research team was very flexible and waited until the stakeholders were available and scheduled the meetings at their convenience. This has led to a high acceptance rate. All of the invited stakeholders except for one agreed to participate in this study. The main reason for non-participation was the lack of time. As such, an experienced stakeholder from the same institution was nominated.

Comment 1.6: The most glaring limitation of the study is that this reviewer was not able to view the actual interview questions and structure of the interview (preface, conclusion, etc.). The details of the wording of the interview questions (including their scope of coverage, but also the neutrality or slanting of the wording of the questions) is crucial in generating information and ultimately the creation of themes. The second paragraph on page 7 should therefore be expanded substantially to include these details.

Response: As suggested by the reviewer, kindly find below a copy of the interview guide. We have integrated the interview guide in the methodology section in the manuscript on page 8-9.

1- Please describe your experiences in the pharmacy sector in Lebanon?

2- What is your opinion on the labor market of Lebanese pharmacists?

- What needs to be improved?

- Why do you think this is the case?

3- What necessary measures need to be implemented to ensure future balance in the pharmacy labor market in Lebanon?

- Why would these measures be important?

- How could they be implemented?

4- What are the requirements to upscale the role of pharmacist in Lebanon?

- What are the impediments?

- What needs to be done to overcome them?

- Who are the responsible parties?

5- How do you describe the practice environment of pharmacists in Lebanon?

- Why do you think this is the case?

- How do you think this could be improved?

6- Are there any additional issues or improvements you wish to highlight?

7- Who else should we speak with to help answer our questions?

Comment 1.7: What was the process (which should have been identified a priori to the study's implementation) by which possible disagreements in the creation of the themes were resolved?

Response: We are happy to elaborate on this point. It is common for different research members to disagree about the appropriateness of codes used for labeling datasets in qualitative analysis. In our study, two members of the research team were responsible for coding and met regularly to focus on identifying points of probable inconsistency and resolve disagreements. Disagreements that could not be resolved were referred to a third team member; however, consensus was reached very often. We have added this process to the manuscript on page 9.

Comment 1.8: Please better and more precisely explain what you mean by "A preliminary data analysis was performed in order to identify issues that need further investigation." This is highly ambiguous and be interpreted in many ways, some of which may undercut the legitimacy of the research. I am not saying this did happen, but it should be clarified to covey to a reader that it did not happen.

Response: We apologize for being unclear, and we thank you for giving us the opportunity to interpret this point. During the data analysis phase, transcribed interviews were comprehensively read in order to gain preliminary insight into the data. The aim of this early stage of thematic analysis is to get researchers familiarized with the responses of the interviews and sensitized to early themes. We have clarified this point in the manuscript on page 9.

Comment 1.9: Please explain in more detail your coding process, what words and expressions were used to identify the key concepts. Again, this is the "art" of qualitative research, and it should be described in more detail so the readers know exactly what you are trying to accomplish.

Response: Thank you for the suggestion. Transcribed interviews were imported to Dedoose, a qualitative analysis software (Lieber, 2014). We used the grounded theory approach in our analysis, a process of coding that uses phrases and terms used by interviewees for developing codes (Khan, 2014). Two members of the research team completed inductively, line-by-line coding for the transcripts without the use of a priori coding scheme. Codes were attached to excerpts, and an initial set of codes was developed from the recurring ideas and discussion points. Multiple rounds of co-coding were applied until consensus on codes definitions was reached. Duplicate codes were removed and overlapping codes were merged. Then, the identified set of codes was explored to form sub-themes from the conceptually related codes. Finally, sub-themes were grouped to form overarching themes. The themes were applied to each transcript, with amendments made if new codes emerged. The final list of themes and sub-themes was approved by all research team members. We have explained the coding process in more detail on page 9 in the manuscript.

Comment 1.10: The second "Contributing Factors to the Oversupply" of Pharmacists in Lebanon" is superficial and needs much greater development (greater depth of analysis), as well as tied to the literature. I think what is contained in this section is fine as a starting point. But there is really no information in each subsection that would not be intuitively obvious to an individual with (even rudimentary) knowledge of the industry. It is important to not only summarize the responses, but to use them to identify novel research questions or to identify previously undiscussed policy issues. For example, the first idea and subsection discusses the clauses concept identified in the introduction. OK; certain countries use clauses to restrict supply. Is the Lebanese educational system designed to enforce clauses? What would it take to enact a clausus in terms of reform to the pharmacy educational system? Was any stakeholder able to identify what the correct number of students admitted to pharmacy school is or approximately should be?

What is reported is too superficial to be of use to identifying research questions or specific directions for future policy research, which is the goal of any qualitative study.

Similar types of issues pervade the remainder of this section. Since this section touches on many major themes, it is infeasible to address points of detail for each of these sections, except to note that each point, while entirely valid in premise, should be expanded with depth of analysis to ensure that the manuscript appropriately and consistently accomplishes its objectives.

Response: We thank the reviewer for the valuable feedback, the team have extensively revised the discussion section to ensure contextualization of all policy options while maintaining a proper word limit. Additional input was added throughout the discussion section on pages 19 and 20. The authors acknowledge that numerus clausus would be difficult to implement knowing the nature of the Lebanese free market educational sector. They also acknowledge that numerus clausus alone would not be enough to bring balance to the labor market and should be coupled with other policy options. As such, other solutions to regulate the pharmacists supply and demand were mentioned in the discussion, including expanding pharmacists’ scope of practice, facilitating the integration of pharmacists in labor markets of countries experiencing shortages, and creating cross-sector job opportunities. All the discussed policy options require concerted efforts from various stakeholders and academic institutions to ensure proper implementation. Similarly, forecasting and analyzing future workforce trends require comprehensive assessment and accurate data to ensure the validity of the generated models. Though it would be challenging to obtain accurate population statistics, the forecasting model is necessary to guide the pharmacy workforce development in the future.

Comment 1.11: In the Conclusions section you mention the creation of a forecasting model. I think this is a good idea. However, there are two issues that should be addressed here. First, a model should forecast with a purpose, and include forecasts that anticipate or predict the effects of specific policy responses. Other than simply forecasting graduates and current openings, what should the model specifically address as the most pressing issue? Is it the clauses, expanded scope of practice, etc.? Second, forecasting itself is not a political process. The model is built to forecast phenomena based on the needs of policy holders. The results are used to inform policy actions. But the model itself should be designed and implemented based on rigorous scientific standards, not on the consensus of politicians or stakeholders.

Response: Thank you for your comment, further input into the generation of the forecasting model within the Lebanese context have been added, please check page 19 in the manuscript. The main purpose of the forecasting model is to reflect on the adequacy of current number of pharmacists to address the needs of the population. It also provides advice on the future anticipated number of pharmacists. On that front, the authors believe that the forecasting model would be more likely guiding policy formulation to address market disbalances and optimize the use of pharmacists in serving individuals and communities. We strongly concur with the reviewer that for this model to be of utility, has to be based on rigorous scientific standards and be shielded to the extent possible from the interference of politicians and biases of stakeholders. This is why the authors call for the engagement of experts from academic institutions and international agencies to safeguard the integrity of the process and the validity of the findings.

Comments from Reviewer #2

The authors would like to extend their deep gratitude to reviewer #2 for the helpful feedback. We found great value in your suggested edits and will use them as a guide to improve the writeup, comprehensiveness and clarity of this manuscript.

Please see below a point-by-point response to your comments and suggestions.

Comment 2.1: The article is well written and establishes data to support its main points. The lack of a validated interview tool may be an important weakness to point out. The summary and analysis of the data in the results and discussion sections are clear and well explained.

Response: Thank you for providing your valuable feedback on the manuscript. We are sorry for missing the inclusion of the interview guide in the first submission. We have now integrated it in the methodology section in the manuscript on page 8-9.

Comment 2.2: It is challenging to remove writer, interviewer and interviewee bias from a manuscript like this. The authors attempt to reduce this and provide information in the limitation section. Perhaps even more emphasis of this point should be attempted in the limitation section.

Response: We are happy to provide additional information on the authors’ attempt to reduce biases in this qualitative study. In this study, researchers avoided pre-existing assumptions and interpretations that support existing beliefs and hypotheses. On the same note, the authors did their best to keep the questions in the interview schedule simple, non-leading, with minimal wording bias to avoid influencing the responses of the interviewees. This point was added to the limitations section in the manuscript (page 23).

Comment 2.3: More support could have been provided to the information about limitation of pharmacists from foreign graduates getting licensed could have been offered. Additionally, consideration of the impact/problems/issues that may result from overall more regulation should have been discussed further.

Response: Thank you for pointing this out. As suggested by the reviewer, we added more information on the integration of foreign trained pharmacists (page 18 in the manuscript). The challenge here is that foreign trained pharmacists can easily practice in Lebanon after passing an exam. However, the surplus of pharmacists is not easily integrated into the labor markets of other countries. This is due to the absence of an agreement between Lebanon and other countries that allows pharmacists trained in Lebanon to practice outside. It is worth noting that foreign trained pharmacists represent 30% of currently practicing pharmacists in Lebanon, whereas only 8% of pharmacists trained in Lebanon are practicing outside (Alameddine et al., 2019).

While we call on the stakeholders to enforce stricter evidence-based regulations to the market, we wish to stress that this process should always be dynamic and guided by evidence rather than the whims of politicians or the biases of policy makers. With the fast-changing environment that is witnessed globally, it is imperative to ensure a nimble, dynamic and evidence based regulatory process. Therefore, any intervention should be coupled with ongoing monitoring and periodic review of supply and demand in order to capture unintended consequences and address them in a timely manner. This point has been added to the discussion in the manuscript (page 20-21).

References

Alameddine, M., Karroum, K. B., & Hijazi, M. A. (2019). Upscaling the pharmacy profession in Lebanon: workforce distribution and key improvement opportunities. Human Resources for Health, 17(1), 47.

Bates, I., John, C., Seegobin, P., & Bruno, A. (2018). An analysis of the global pharmacy workforce capacity trends from 2006 to 2012. Human Resources for Health, 16(1), 1-9.

Brown, D. L. (2013). A looming joblessness crisis for new pharmacy graduates and the implications it holds for the academy. American journal of pharmaceutical education, 77(5).

Dalton, K., & Byrne, S. (2017). Role of the pharmacist in reducing healthcare costs: current insights. Integrated pharmacy research & practice, 6, 37.

Ghaibi, S., Ipema, H., & Gabay, M. (2015). ASHP guidelines on the pharmacist’s role in providing drug information. American Journal of Health-System Pharmacy, 72(7), 573-577.

Hallit, S., Sacre, H., Hajj, A., Sili, G., Zeenny, R. M., & Salameh, P. (2019). Projecting the future size of the Lebanese pharmacy workforce: forecasts until the year 2050. International Journal of Pharmacy Practice, 27(6), 582-588.

Khan, S. N. (2014). Qualitative research method: Grounded theory. International Journal of Business and Management, 9(11), 224-233.

Lieber, E. (2014). Dedoose (Beginner Workshop)—Getting Started with Your Qualitative and Mixed Methods Data Management, Analysis, and Presentation.

OECD. (2004). Migration for Employment: Bilateral Agreements at a crossroads. OECD Publishing.

Strauss, A. (1998). 8c Corbin, J.(1998). Basics of qualitative research: Techniques and procedures for developing grounded theory. Thousand Oaks, CA: Sage.

Vaillancourt, R. (2011). Pharmacists: the guardians of safe medication use. The Canadian Journal of Hospital Pharmacy, 64(1), 5.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Vijayaprakash Suppiah

29 Oct 2020

A profession in danger: Stakeholders’ perspectives on supporting the pharmacy profession in Lebanon

PONE-D-20-28091R1

Dear Dr. Hijazi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Vijayaprakash Suppiah, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have made a very thorough and meaningful attempt to address my comments. Most of my major concerns with the manuscript have now been addressed. I comment the authors for their efforts to improve the manuscript.

Reviewer #2: All of my areas of recommendation have been addressed from my first review. I support the edits and responses received to my comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Vijayaprakash Suppiah

3 Nov 2020

PONE-D-20-28091R1

A profession in danger: Stakeholders’ perspectives on supporting the pharmacy profession in Lebanon

Dear Dr. Hijazi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Vijayaprakash Suppiah

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    Data cannot be shared publicly because it contains potentially identifying information of human subjects. Data are available from the American University of Beirut Institutional Data Access/Ethics Committee (contact via email: irb@aub.edu.lb) for researchers who meet the criteria for access to confidential data.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES